BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 21561742)

  • 1. Interventions to improve adherence to antipsychotic medication in patients with schizophrenia--a review of the past decade.
    Barkhof E; Meijer CJ; de Sonneville LM; Linszen DH; de Haan L
    Eur Psychiatry; 2012 Jan; 27(1):9-18. PubMed ID: 21561742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventions to improve medication adherence in schizophrenia.
    Zygmunt A; Olfson M; Boyer CA; Mechanic D
    Am J Psychiatry; 2002 Oct; 159(10):1653-64. PubMed ID: 12359668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of motivational interviewing-based adherence therapy for schizophrenia spectrum disorders: a randomized controlled trial.
    Chien WT; Mui JH; Cheung EF; Gray R
    Trials; 2015 Jun; 16():270. PubMed ID: 26072311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does adherence therapy improve medication adherence among patients with schizophrenia? A systematic review.
    Hegedüs A; Kozel B
    Int J Ment Health Nurs; 2014 Dec; 23(6):490-7. PubMed ID: 25279684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insight and medication adherence in schizophrenia: An analysis of the CATIE trial.
    Kim J; Ozzoude M; Nakajima S; Shah P; Caravaggio F; Iwata Y; De Luca V; Graff-Guerrero A; Gerretsen P
    Neuropharmacology; 2020 May; 168():107634. PubMed ID: 31077729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ability of multifamily groups to improve treatment adherence in Mexican Americans with schizophrenia.
    Kopelowicz A; Zarate R; Wallace CJ; Liberman RP; Lopez SR; Mintz J
    Arch Gen Psychiatry; 2012 Mar; 69(3):265-73. PubMed ID: 22393219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature.
    Lacro JP; Dunn LB; Dolder CR; Leckband SG; Jeste DV
    J Clin Psychiatry; 2002 Oct; 63(10):892-909. PubMed ID: 12416599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interventions to improve antipsychotic medication adherence: review of recent literature.
    Dolder CR; Lacro JP; Leckband S; Jeste DV
    J Clin Psychopharmacol; 2003 Aug; 23(4):389-99. PubMed ID: 12920416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does compliance therapy improve use of antipsychotic medication?
    Ilott R
    Br J Community Nurs; 2005 Nov; 10(11):514-9. PubMed ID: 16301926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication adherence in patients with schizophrenia.
    Phan SV
    Int J Psychiatry Med; 2016; 51(2):211-9. PubMed ID: 27079779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia.
    Leucht S; Heres S
    J Clin Psychiatry; 2006; 67 Suppl 5():3-8. PubMed ID: 16822090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving treatment adherence in patients with schizophrenia.
    Kane JM
    J Clin Psychiatry; 2011 Sep; 72(9):e28. PubMed ID: 21951990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence therapy versus routine psychiatric care for people with schizophrenia spectrum disorders: a randomised controlled trial.
    Chien WT; Mui J; Gray R; Cheung E
    BMC Psychiatry; 2016 Feb; 16():42. PubMed ID: 26911397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Motivational Interviewing on Medication Adherence in Schizophrenia.
    Vanderwaal FM
    Issues Ment Health Nurs; 2015; 36(11):900-4. PubMed ID: 26631862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective study of risk factors for nonadherence with antipsychotic medication in the treatment of schizophrenia.
    Ascher-Svanum H; Zhu B; Faries D; Lacro JP; Dolder CR
    J Clin Psychiatry; 2006 Jul; 67(7):1114-23. PubMed ID: 16889456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication Adherence Decisions in Patients With Schizophrenia.
    Kikkert MJ; Dekker J
    Prim Care Companion CNS Disord; 2017 Dec; 19(6):. PubMed ID: 29216418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An RCT of adherence therapy for people with schizophrenia in Chiang Mai, Thailand.
    Maneesakorn S; Robson D; Gournay K; Gray R
    J Clin Nurs; 2007 Jul; 16(7):1302-12. PubMed ID: 17584349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of motivational interviewing on medication adherence and hospitalization rates in nonadherent patients with multi-episode schizophrenia.
    Barkhof E; Meijer CJ; de Sonneville LM; Linszen DH; de Haan L
    Schizophr Bull; 2013 Nov; 39(6):1242-51. PubMed ID: 24072808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipsychotic medication adherence in schizophrenia.
    Byerly MJ; Nakonezny PA; Lescouflair E
    Psychiatr Clin North Am; 2007 Sep; 30(3):437-52. PubMed ID: 17720031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic alliance, a stake in schizophrenia].
    Charpentier A; Goudemand M; Thomas P
    Encephale; 2009 Feb; 35(1):80-9. PubMed ID: 19250998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.